Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results
Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25Phase 3 CAPTIVATE trial of ...
Helsinki4y
MMN2018: The 8th Mismatch Negativity conference
MMN2018: 8th Mismatch Negativity conference “MMN from basic science to clinical applications” The 8th Mismatch Negativity conference “MMN from basic science to clinical applications”, celebrating 40th ...